Hypercalcemia and diabetes insipidus in a patient previously treated with lithium

Nature Clinical Practice Nephrology

Volumn 3, Issue 7, 2007, Pages 397-404

  Khairallah, Walid ^a   Fawaz, Ahmad ^b   Brown, Edward M ^c   El Hajj Fuleihan, Ghada ^b  

^a Gulf Diabetes Specialist Center   (Bahrain)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Calcium sensing receptor; Hypercalcemia; Lithium; Nephrogenic diabetes insipidus; Thiazide

Indexed keywords

HYDROCHLOROTHIAZIDE; LITHIUM; PAMIDRONIC ACID; PROTEIN; SODIUM; THIAZIDE DIURETIC AGENT;

AGED; ARTICLE; BLOOD CULTURE; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS LEVEL; DEHYDRATION; DIABETES INSIPIDUS; DRUG INTOXICATION; DRUG WITHDRAWAL; FEMALE; FLUID INTAKE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; LABORATORY TEST; NEPHROGENIC DIABETES INSIPIDUS; NEPHROLITHIASIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN RESTRICTION; SCHIZOAFFECTIVE PSYCHOSIS; SEPSIS; SERUM OSMOLALITY; SODIUM RESTRICTION; URINE CULTURE; URINE OSMOLALITY;

AGED; DIABETES INSIPIDUS, NEPHROGENIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY CALCULI; LITHIUM CARBONATE; LONG-TERM CARE; PARATHYROIDECTOMY; RISK ASSESSMENT; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 34250821686     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0525     Document Type: Article

References (26)

1. Brown EM and MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81: 239-297
2. Garofeanu CG et al. (1998) Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis 45: 626-637
3. Livingstone C and Rampes H (2006) Lithium: a review of its metabolic adverse effects. J Psychopharmacol 20: 347-355
4. Presne C et al. (2003) Li-induced nephropathy: rate of progression and prognostic factors. Kidney Int 64: 585-592
5. Timmer RT and Sands JM (1999) Lithium intoxication. J Am Soc Nephrol 10: 666-674
6. Mallette LE and Eichhorn E (1986) Effects of lithium carbonate on human calcium metabolism. Arch Intern Med 146: 770-776
7. Mak TW et al. (1998) Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study. J Clin Endocrinol Metab 83: 3857-3859
8. El-Hajj Fuleihan G et al. (2002) The familial benign hypocalciuric hypercalcemic syndromes. In Principles of Bone Biology, 1031-1045 (Eds Bilezikian JP et al.) San Diego: Academic Press
9. Haden ST et al. (1997) Alterations in parathyroid dynamics in lithium-treated subjects. J Clin Endocrinol Metab 82: 2844-2848
10. Bendz H et al. (1996) Hyperparathyroidism and long-term lithium therapy - a cross-sectional study and the effect of lithium withdrawal. J Intern Med 240: 357-365
11. Nordenstrom J et al. (1992) Hyperparathyroidism associated with treatment of manic-depressive disorders by lithium. Eur J Surg 158: 207-211
12. Hundley JC et al. (2005) Revisiting lithium-associated hyper parathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery 138: 1027-1032
13. Awad SS et al. (2003) Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 27: 486-488
14. Boton R et al. (1987) Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 10: 329-345
15. Oksche A and Rosenthal W (1998) The molecular basis of nephrogenic diabetes insipidus. J Mol Med 76: 326-337
16. Schrier RW (2006) Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 17: 1820-1832
17. Christensen S et al. (1985) Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats. J Clin Invest 75: 1869-1879
18. Christensen BM et al. (2004) Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI. Am J Physiol Cell Physiol 286: C952-C964
19. Hensen J et al. (1996) Lithium induced polyuria and renal vasopressin receptor density. Nephrol Dial Transplant 11: 622-627
20. Bendz H (1983) Kidney function in lithium-treated patients: a literature survey. Acta Psychiatr Scand 68: 303-324
21. Earm JH et al. (1998) Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats. J Am Soc Nephrol 9: 2181-2193
22. 1 receptors. J Clin Invest 100: 1941-1950
23. Kim GH et al. (2004) Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel. J Am Soc Nephrol 15: 2836-2843
24. Bichet DG (2007) Treatment of nephrogenic diabetes insipidus. In UpToDate (Ed. Rose BD) Waltham, MA: UpToDate
25. st century. J Clin Endocrinol Metab 87: 5353-5361
26. Sloand JA and Shelly MA (2006) Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis 48: 832-837